Neuroimaging and CSF Biomarker RFP
Supports biomarker projects that improve diagnosis, imaging, or trial design for Alzheimer's disease.
About
The Alzheimer's Drug Discovery Foundation's Neuroimaging and CSF Biomarker RFP supports biomarker work for Alzheimer's disease and related dementias. It sits inside ADDF's wider mission to accelerate drugs that prevent, treat, and cure the disease, and it reflects the foundation's venture-philanthropy model rather than a conventional unrestricted grant line. The program is one of ADDF's recurring …
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.